🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients

RecruitingNAAges 40 Years - 65 YearsAllKirsehir Ahi Evran Universitesi
NCT07231822 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Osteoporosis is a progressive disease characterised by a decrease in bone mass, deterioration in bone microarchitecture, and increased fragility. Etiologically, it is divided into two types: primary (postmenopausal and senile) and secondary. Postmenopausal women are particularly at high risk; it is seen in more than 80% of women over the age of 50 and in almost all individuals over the age of 75. With menopause, bone mineral density decreases, which negatively affects neuromuscular functions, leading to balance disorders, decreased walking speed, and an increased risk of falls. Falls are the primary cause of osteoporotic fractures and result in functional loss, morbidity, mortality, and increased healthcare costs. Exercise is effective in reducing bone loss; in recent years, therapeutic virtual reality and exercise games (exergames) have come to the fore. However, the literature on the e

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Postmenopausal women aged 50-75 years * Individuals diagnosed with osteoporosis based on Dual-Energy X-ray Absorptiometry (DEXA) measurement (T-score ≤ -2.5) * Having been in menopause for at least 1 year * Being able to walk independently (without the use of assistive devices) * Volunteering to participate in the study and having provided informed consent * Having adequate cognitive function (e.g., Mini Mental Test ≥ 24) Exclusion Criteria: * Secondary osteoporosis diagnosis (e.g. endocrine, metabolic or drug-induced causes) * History of lower limb fracture or surgical intervention within the last 6 months * Individuals with severe cardiovascular, neurological, or musculoskeletal disorders * Individuals with vestibular or visual impairments that may affect balance * Intolerance to virtual reality applications (e.g., dizziness, nausea, etc.) * Individuals who have participated in a regular physiotherapy or exercise programme within the last 3 months
💊

What it tests

  • Conventional treatment
  • Virtual reality treatment
📍

Where

1 site
Kırşehir Ahi Evran University
Center, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy